SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Perry who wrote (690)5/14/1998 8:40:00 PM
From: gaddis  Read Replies (2) of 834
 
No, I checked the documentation, and the Phase 3 results came from a 304 patient source population. Go to tbc.com and you will find these results mentioned. Why do you say that you would think it still too small a sample ? Other companies have had comparably smaller studies and still won approval for their products. It's interesting that the one person on this thread who was negative on TXB stated that the way TXB conducted the trials would cause them to be rejected by the FDA despite "statistically significant" results. Why, with all the overvalued stocks around would he pick out TXB ? So many unanswered questions... And where are all the people that shouted this fellow down so strongly ?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News